Finally, coronavirus vaccines and treatments should serve as a tailwind for the health care industry as a whole. Hardy is projecting mid-single-digit earnings growth over the long term, including 9% earnings per share growth in fiscal 2020. CFRA has a "strong-buy" rating and a $109 price target for ABC stock.